Positron emitter labeled enzyme inhibitors
This invention involves a new strategy for imaging and mapping enzyme activity in the living human and animal body using positron emitter-labeled suicide enzyme inactivators or inhibitors which become covalently bound to the enzyme as a result of enzymatic catalysis. Two such suicide inactivators for monoamine oxidase have been labeled with carbon-11 and used to map the enzyme subtypes in the living human and animal body using PET. By using positron emission tomography to image the distribution of radioactivity produced by the body penetrating radiation emitted by carbon-11, a map of functionally active monoamine oxidase activity is obtained. Clorgyline and L-deprenyl are suicide enzyme inhibitors and irreversibly inhibit monoamine oxidase. When these inhibitors are labeled with carbon-11 they provide selective probes for monoamine oxidase localization and reactivity in vivo using positron emission tomography.
- Assignee:
- Dept. of Energy, Washington, DC
- Patent Number(s):
- US 4913891; A
- Application Number:
- PPN: US 7-052921A; TRN: 90-024672
- OSTI ID:
- 5664820
- Resource Relation:
- Patent File Date: 22 May 1987
- Country of Publication:
- United States
- Language:
- English
Similar Records
Positron emitter labeled enzyme inhibitors
(/sup 11/C)clorgyline and (/sup 11/C)-L-deprenyl and their use in measuring functional monoamine oxidase activity in the brain using positron emission tomography
Related Subjects
62 RADIOLOGY AND NUCLEAR MEDICINE
ENZYME INHIBITORS
CHEMICAL COMPOSITION
ENZYMES
INHIBITION
POSITRON COMPUTED TOMOGRAPHY
LABELLED COMPOUNDS
AMINES
BIOCHEMICAL REACTION KINETICS
ENZYME ACTIVITY
COMPUTERIZED TOMOGRAPHY
DIAGNOSTIC TECHNIQUES
EMISSION COMPUTED TOMOGRAPHY
KINETICS
ORGANIC COMPOUNDS
REACTION KINETICS
TOMOGRAPHY
550200* - Biochemistry
550601 - Medicine- Unsealed Radionuclides in Diagnostics